Scilex Holding (SCLX) Debt Ratio (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Debt Ratio of 0.28 for Q1 2026, down 44.91% year-over-year from 0.5 in Q1 2025, and down 5.04% quarter-over-quarter from 0.29 in Q4 2025.
Scilex Holding (SCLX) Debt Ratio (2021 - 2026) Analysis & Trends
Scilex Holding's Debt Ratio history runs 6 years deep, the most recent figure standing at 0.28 for Q1 2026.
- In Q1 2026, Debt Ratio fell 44.91% year-over-year to 0.28; the TTM figure through Mar 2026 stood at 0.28 (down 44.91% YoY), while the FY2025 annual figure was 0.29, down 24.61% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.28, down from 0.29 in the prior quarter.
- The five-year high for Debt Ratio was 1.52 in Q3 2023, with the low at 0.01 in Q2 2022.
- The 5-year median for Debt Ratio is 0.43 (2024), against an average of 0.59.
- The sharpest annual moves came in 2023 and 2025: Debt Ratio soared 5079.05% in 2023, then tumbled 83.2% in 2025.
- Scilex Holding's Debt Ratio stood at 0.03 in 2022, then soared by 4128.35% to 1.24 in 2023, then tumbled by 68.97% to 0.38 in 2024, then decreased by 24.61% to 0.29 in 2025, then decreased by 5.04% to 0.28 in 2026.
- Business Quant data shows SCLX's Debt Ratio at 0.28 in Q1 2026, 0.29 in Q4 2025, and 0.17 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.08 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 0.25 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.66 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.58 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 0.31 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -0.31 |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn | 0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.28 |
| Dec 31, 2025 | 0.29 |
| Sep 30, 2025 | 0.17 |
| Jun 30, 2025 | 0.48 |
| Mar 31, 2025 | 0.50 |
| Dec 31, 2024 | 0.38 |
| Sep 30, 2024 | 0.99 |
| Jun 30, 2024 | 1.00 |
| Mar 31, 2024 | 1.20 |
| Dec 31, 2023 | 1.24 |
| Sep 30, 2023 | 1.52 |
| Jun 30, 2023 | 0.13 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.01 |
| Dec 31, 2021 | 1.41 |